REPLY
Clinical Use of Apolipoprotein Quantitation
Daniel J. Rader, MD
1 January 1995 | Volume 122 Issue 1 | Pages 69-70
IN RESPONSE:
In our proposed algorithms, HDL cholesterol levels are initially determined as part of the fasting lipid panel. We agree that a decision to use drug therapy because of a low HDL cholesterol level could obviate the need for further apolipoprotein quantitation. However, because drug therapy for a low HDL cholesterol level is not established practice, we feel that the additional data provided by the apo B and Lp(a) levels cold be useful in determining drug therapy for persons with low HDL cholesterol levels.
Two unfortunate misprint appeared in our review. As Dr. Padder and colleagues and Dr. Johnson and colleagues pointed out, a 10% decrease in apo B levels was associated with a 22% decrease in coronary artery disease mortality, and a 10% increase in Lp(a) levels was associated with a 3% increase in the risk for coronary artery disease.
Finally, we applaud the international efforts to standardize apo A-I and apo B assays and look forward to when they will be fully implemented. We agree that the BUPA data support neither apo A-I nor HDL cholesterol as a measurement for population-based screening for coronary heart disease but cannot readily explain the discrepancy between the findings of this study and those of others.
|
Author and Article Information
|
|---|
 Top
 Author & Article Info
|
|---|
University of Pennsylvania Medical Center; Philadelphia, PA 19104
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Article
